1157 / 1481
Involved field or Elective Nodal RT
A Phase III trial in NSCLC
Yuan et al Am.J.Clin.Oncol.
ENI 44 Gy 60-64 Gy
6-7.5 w
IFI 68-74 Gy
7-9 w
CH
CH
CH
CH
CH CH
Chemotherapy
DDP 25 mg/m
2
d1-3 q 3w
VP16 75 mg/m
2
d1-5
|
|
1157 / 1481
Involved field or Elective Nodal RT
A Phase III trial in NSCLC
Yuan et al Am.J.Clin.Oncol.
ENI 44 Gy 60-64 Gy
6-7.5 w
IFI 68-74 Gy
7-9 w
CH
CH
CH
CH
CH CH
Chemotherapy
DDP 25 mg/m
2
d1-3 q 3w
VP16 75 mg/m
2
d1-5